Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

BioLineRx inlicenses BL-1060 for fatty liver disease

March 21, 2005

MNTX shows efficacy in the treatment of opioid-induced constipation

March 17, 2005

ViroPharma and Wyeth discontinue development of HCV-086

March 17, 2005

Janssen describes new treatments for gastrointestinal disorders in recent patents

March 15, 2005

FDA Advisory Committee recommends approval of Baraclude for hepatitis B

March 15, 2005

Nikem Research discloses novel tachykinin receptor antagonists

March 15, 2005

Two phase II clinical trials report benefits with alvimopan in bowel dysfunction

March 15, 2005

Enrollment completed in three-year Enteryx procedure trial

March 14, 2005

Corixa and Lorantis to develop therapeutic hepatitis B vaccine

March 7, 2005

AZD-0865 prevents gastric acid secretion following single and repeated dosing

March 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...